We would be interested in learning how our members are rising to challenges posed by the pandemic. Please don't hesitate to use this form to share any relevant information, insight and resources with us which we can post on our dedicated COVID-19 Resources webpage on the SIOP website.
Hi, my name is Yoshiko Nakano, and I am a pediatric oncologist in Japan. Shinsuke Hirabayashi and I will join the YI committee for the upcoming 50th SIOP Congress in Kyoto. Today, we would like to write about some aspects of the current status of pediatric hematology/oncology in Japan.
Hi readers! My name is Francianne and I am a Ph.D. student in Brazil. Today I will discuss the particularities of epidemiologic research in my country and share the main findings of Brazilian studies on the epidemiology of childhood cancer.
My name is Liliana Vásquez, pediatric oncologist from Lima, Peru and I am happy to announce the II SLAOP-SIOP session of Young Investigators to be held on March 14, 2018 at IOP / GRAACC / UNIFESP in Sao Paulo, Brazil (Pre-congress meeting of #SLAOP2018).
Hi Everyone! My name is Gemma, I’m a SIOP YI Board member. Today I am posting on behalf of Dr Guillaume Bergthold, who shares his experiences of his Fellowship in Industry with Roche.
Today I am posting on behalf of Jack Brzezinski, who today is writing about integrating clinical and research interests. Take it away Jack!
It can be tough to be a successful scientist at the same time as you carry on a clinical practice. On one end, you have the same responsibilities to your patients as any other clinician. On the other end, you are trying to compete for the same grant money as pure scientists who can focus on their science and don’t have a clinical practice to worry about. However, there are also distinct advantages to being a mixed clinician-scientist and with a little bit of time management you can use the job mix to your advantage.